mesalamine oral
Selected indexed studies
- Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis. (J Crohns Colitis, 2021) [PMID:33433562]
- Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis. (Inflamm Bowel Dis, 2012) [PMID:22644954]
- Pentasa (Mesalamine). (Gastroenterol Nurs, 1993) [PMID:8286430]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications. (2016) pubmed
- Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis. (2021) pubmed
- Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis. (2012) pubmed
- Pentasa (Mesalamine). (1993) pubmed
- MMX mesalamine. (2006) pubmed
- Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention. (2006) pubmed
- Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study. (2017) pubmed
- Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations. (2017) pubmed
- Mesalamine-induced lung toxicity. (1996) pubmed
- Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. (2020) pubmed